Diabetes costs NHS £2 billion
This article was originally published in Clinica
Improved early monitoring for diabetes could reduce the massive £2 billion NHS expenditure on diabetes care, says a report published on August 27th by the King's Fund. "More than half of this huge sum is spent treating the complications of the disease, which could be reduced by improving preventative care," claims Prof Harry Keen, chairman of the British Diabetic Association, which commissioned the report from the UK independent health policy think-tank.
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.